fda

Cigarette makers shifted stance on nicotine patches, gum, study shows

The use of nicotine patches, gum, lozenges, inhalers or nasal sprays — together called “nicotine replacement therapy,” or NRT — came into play in 1984 as prescription medicine, which when combined with counseling, helped smokers quit. But in 1996, at the urging of pharmaceutical companies, the U.S. Food and Drug…

Senate Passes Bill Providing $1 Billion for Prevention and Treatment of Opioid Addiction

The U.S. Senate on Wednesday passed the 21st Century Cures Act, which includes $1 billion in new funding to prevent and treat opioid addiction. The House approved the measure last week. The legislation includes funding for cancer research and mental health treatment, and will help the Food and Drug Administration…

FDA Considers Whether Naloxone Devices Should Contain Standard Dose of Drug

The Food and Drug Administration (FDA) will determine whether naloxone devices distributed in communities should contain a standard dose of the opioid overdose antidote, according to U.S. News & World Report. Drug companies that make naloxone devices do not agree on how much naloxone should be administered following an opioid…

Judge Rules Tobacco Label Change Does Not Create New Product

If a tobacco company changes a label for a product, the Food and Drug Administration (FDA) cannot consider it a new product for regulatory purposes, a federal judge ruled this week. U.S. District Judge Amit Mehta said changing the quantity of a product in packaging does make it a new…

Buprenorphine Implant to Treat Opioid Addiction Approved by FDA

The Food and Drug Administration (FDA) has approved Probuphine, an implant that contains the opioid addiction treatment buprenorphine. The drug has been available in oral form for 14 years, CNBC reports. Probuphine consists of four small stick-like implants that are inserted in the upper arm, during a doctor’s visit that…